Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth

M. Marzioni, P. Invernizzi, C. Candelaresi, M. Maggioni, S. Saccomanno, C. Selmi, C. Rychlicki, L. Agostinelli, B. Cassani, M. Miozzo, S. Pasini, G. Fava, G. Alpini, A. Benedetti

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background/Aims: Incidence of cholangiocarcinoma is increasing worldwide, yet remaining highly aggressive and with poor prognosis. The mechanisms that drive cholangiocyte transition towards malignant phenotype are obscure. Cholangiocyte benign proliferation is subjected to a self-limiting mechanism based on the autocrine release of endogenous opioid peptides. Despite the presence of both, ligands interact with δ opioid receptor (OR), but not with μOR, with the consequent inhibition of cell growth. We aimed to verify whether cholangiocarcinoma growth is associated with failure of opioidergic regulation of growth control. Methods: We evaluated the effects of OR selective agonists on cholangiocarcinoma cell proliferation, migration and apoptosis. Intracellular signals were also characterised. Results: Activation of μOR, but not δOR, increases cholangiocarcinoma cell growth. Such an effect is mediated by ERK1/2, PI3K and Ca2+-CamKIIα cascades, but not by cAMP/PKA and PKCα. μOR activation also enhances cholangiocarcinoma cell migration and reduces death by apoptosis. The anti-apoptotic effect of μOR was PI3K dependent. Conclusions: Our data indicate that cholangiocarcinoma growth is associated with altered opioidergic regulation of cholangiocyte biology, thus opening new scenarios for future surveillance or early diagnostic strategies for cholangiocarcinoma.

Original languageEnglish
Pages (from-to)523-533
Number of pages11
JournalDigestive and Liver Disease
Volume41
Issue number7
DOIs
Publication statusPublished - Jul 2009

Fingerprint

Cholangiocarcinoma
Human Development
Opioid Receptors
Growth
Phosphatidylinositol 3-Kinases
Cell Movement
Apoptosis
Opioid Peptides
Cell Proliferation
Ligands
Phenotype
Incidence

Keywords

  • Cholangiocarcinoma
  • Endogenous opioid peptides
  • Proliferation
  • Survival

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. / Marzioni, M.; Invernizzi, P.; Candelaresi, C.; Maggioni, M.; Saccomanno, S.; Selmi, C.; Rychlicki, C.; Agostinelli, L.; Cassani, B.; Miozzo, M.; Pasini, S.; Fava, G.; Alpini, G.; Benedetti, A.

In: Digestive and Liver Disease, Vol. 41, No. 7, 07.2009, p. 523-533.

Research output: Contribution to journalArticle

Marzioni, M, Invernizzi, P, Candelaresi, C, Maggioni, M, Saccomanno, S, Selmi, C, Rychlicki, C, Agostinelli, L, Cassani, B, Miozzo, M, Pasini, S, Fava, G, Alpini, G & Benedetti, A 2009, 'Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth', Digestive and Liver Disease, vol. 41, no. 7, pp. 523-533. https://doi.org/10.1016/j.dld.2008.09.011
Marzioni, M. ; Invernizzi, P. ; Candelaresi, C. ; Maggioni, M. ; Saccomanno, S. ; Selmi, C. ; Rychlicki, C. ; Agostinelli, L. ; Cassani, B. ; Miozzo, M. ; Pasini, S. ; Fava, G. ; Alpini, G. ; Benedetti, A. / Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth. In: Digestive and Liver Disease. 2009 ; Vol. 41, No. 7. pp. 523-533.
@article{fb2d1f712b344f08b866d5cba7de8810,
title = "Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth",
abstract = "Background/Aims: Incidence of cholangiocarcinoma is increasing worldwide, yet remaining highly aggressive and with poor prognosis. The mechanisms that drive cholangiocyte transition towards malignant phenotype are obscure. Cholangiocyte benign proliferation is subjected to a self-limiting mechanism based on the autocrine release of endogenous opioid peptides. Despite the presence of both, ligands interact with δ opioid receptor (OR), but not with μOR, with the consequent inhibition of cell growth. We aimed to verify whether cholangiocarcinoma growth is associated with failure of opioidergic regulation of growth control. Methods: We evaluated the effects of OR selective agonists on cholangiocarcinoma cell proliferation, migration and apoptosis. Intracellular signals were also characterised. Results: Activation of μOR, but not δOR, increases cholangiocarcinoma cell growth. Such an effect is mediated by ERK1/2, PI3K and Ca2+-CamKIIα cascades, but not by cAMP/PKA and PKCα. μOR activation also enhances cholangiocarcinoma cell migration and reduces death by apoptosis. The anti-apoptotic effect of μOR was PI3K dependent. Conclusions: Our data indicate that cholangiocarcinoma growth is associated with altered opioidergic regulation of cholangiocyte biology, thus opening new scenarios for future surveillance or early diagnostic strategies for cholangiocarcinoma.",
keywords = "Cholangiocarcinoma, Endogenous opioid peptides, Proliferation, Survival",
author = "M. Marzioni and P. Invernizzi and C. Candelaresi and M. Maggioni and S. Saccomanno and C. Selmi and C. Rychlicki and L. Agostinelli and B. Cassani and M. Miozzo and S. Pasini and G. Fava and G. Alpini and A. Benedetti",
year = "2009",
month = "7",
doi = "10.1016/j.dld.2008.09.011",
language = "English",
volume = "41",
pages = "523--533",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "7",

}

TY - JOUR

T1 - Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth

AU - Marzioni, M.

AU - Invernizzi, P.

AU - Candelaresi, C.

AU - Maggioni, M.

AU - Saccomanno, S.

AU - Selmi, C.

AU - Rychlicki, C.

AU - Agostinelli, L.

AU - Cassani, B.

AU - Miozzo, M.

AU - Pasini, S.

AU - Fava, G.

AU - Alpini, G.

AU - Benedetti, A.

PY - 2009/7

Y1 - 2009/7

N2 - Background/Aims: Incidence of cholangiocarcinoma is increasing worldwide, yet remaining highly aggressive and with poor prognosis. The mechanisms that drive cholangiocyte transition towards malignant phenotype are obscure. Cholangiocyte benign proliferation is subjected to a self-limiting mechanism based on the autocrine release of endogenous opioid peptides. Despite the presence of both, ligands interact with δ opioid receptor (OR), but not with μOR, with the consequent inhibition of cell growth. We aimed to verify whether cholangiocarcinoma growth is associated with failure of opioidergic regulation of growth control. Methods: We evaluated the effects of OR selective agonists on cholangiocarcinoma cell proliferation, migration and apoptosis. Intracellular signals were also characterised. Results: Activation of μOR, but not δOR, increases cholangiocarcinoma cell growth. Such an effect is mediated by ERK1/2, PI3K and Ca2+-CamKIIα cascades, but not by cAMP/PKA and PKCα. μOR activation also enhances cholangiocarcinoma cell migration and reduces death by apoptosis. The anti-apoptotic effect of μOR was PI3K dependent. Conclusions: Our data indicate that cholangiocarcinoma growth is associated with altered opioidergic regulation of cholangiocyte biology, thus opening new scenarios for future surveillance or early diagnostic strategies for cholangiocarcinoma.

AB - Background/Aims: Incidence of cholangiocarcinoma is increasing worldwide, yet remaining highly aggressive and with poor prognosis. The mechanisms that drive cholangiocyte transition towards malignant phenotype are obscure. Cholangiocyte benign proliferation is subjected to a self-limiting mechanism based on the autocrine release of endogenous opioid peptides. Despite the presence of both, ligands interact with δ opioid receptor (OR), but not with μOR, with the consequent inhibition of cell growth. We aimed to verify whether cholangiocarcinoma growth is associated with failure of opioidergic regulation of growth control. Methods: We evaluated the effects of OR selective agonists on cholangiocarcinoma cell proliferation, migration and apoptosis. Intracellular signals were also characterised. Results: Activation of μOR, but not δOR, increases cholangiocarcinoma cell growth. Such an effect is mediated by ERK1/2, PI3K and Ca2+-CamKIIα cascades, but not by cAMP/PKA and PKCα. μOR activation also enhances cholangiocarcinoma cell migration and reduces death by apoptosis. The anti-apoptotic effect of μOR was PI3K dependent. Conclusions: Our data indicate that cholangiocarcinoma growth is associated with altered opioidergic regulation of cholangiocyte biology, thus opening new scenarios for future surveillance or early diagnostic strategies for cholangiocarcinoma.

KW - Cholangiocarcinoma

KW - Endogenous opioid peptides

KW - Proliferation

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=67349261559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349261559&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2008.09.011

DO - 10.1016/j.dld.2008.09.011

M3 - Article

VL - 41

SP - 523

EP - 533

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 7

ER -